美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · MANE近 30 天 5 則 · 第 1 / 1 頁
- Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic
- Veradermics to Present at Upcoming September Investor Conferences
- Veradermics (MANE) Stock Looks Overvalued After Its 161% Rally
- Is Veradermics (MANE) Still Undervalued After Its 161% Year To Date Run?
- Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade
- Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
- Veradermics (MANE) Positioned to Disrupt Hair Loss Market
- Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months
- Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy
- Veradermics Hair Loss Pill Shows Strong Phase II Signal in Women
- Veradermics’ Oral VDPHL01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout
- Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss
- Can Veradermics (MANE) Climb 27.65% to Reach the Level Wall Street Analysts Expect?
- Is Veradermics, Incorporated (MANE) A Good Stock To Buy Now?
- Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
- Viking Stake In Veradermics Highlights Risky Growth And Ownership Shifts
- Here is Why Veradermics (MANE) is One of the Best Performing NYSE Stocks So Far in 2026
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。